Patients who participated in an intensive lifestyle medicine program before total hip and knee arthroplasty had reduced infection risk and less pain 90 days after surgery compared with those who did ...

Baseline Therapeutics, Inc. (baseline-tx.com) is a San Francisco-based clinical-stage biotechnology company developing breakthrough therapeutics for addiction. Baseline's lead program, BT-001, is a ...

A critical look at metabolically healthy obesity and metabolically unhealthy normal weight—and what they mean for evidence-based, weight-inclusive care.

The latest study from the Sharma Lab at UC Santa Cruz makes the mechanisms of how epigenetic information is established in sperm cells, and how that encoding affects offspring health, a little less of ...

Nutra, the science-driven company behind ProLon, explain why chronic calorie restriction often backfires — and how time-bound metabolic interventions are reshaping the future of sustainable weight ...

Background: Colorectal cancer (CRC) represents a significant public health challenge in China. With the rising prevalence of metabolic disorders such as obesity and diabetes, it is essential to ...

Precision Lifestyle Management: A continuous, personalized behavioral intervention model powered by remote monitoring, AI-enabled digital tools, and coordinated team-based care. This approach supports ...

NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (HOTH), a patient-focused clinical-stage biopharmaceutical company, today issued a comprehensive update on its therapeutic pipeline. The ...

Hoth continues to advance HT-001 in its Phase 2 CLEER-001 clinical trial targeting EGFR-inhibitor–associated rash, a significant unmet need in oncology supportive care. Recent progress includes: ...

Researchers from University of California San Diego have identified 11 genetic regions linked to delay discounting - the tendency to prefer smaller, immediate rewards over larger, delayed ones - ...